News
'Breakthrough' drug may not mean what you think | Reuterswww.reuters.com › article
www.reuters.com
“These clinical endpoints can be surrogate outcomes and don't have to be a direct outcome of the disease,” said coauthor Tamar Krishnamurti, ...
Cost and Impact on the Environment - NYTimes.com
www.nytimes.com
Mar 17, · Tamar Krishnamurti is a postdoctoral fellow in the department of engineering and public policy and at the Tepper School of Business at Carnegie Mellon University.. Updated March 18, 2011, 9:57 AM
Dr. Tamar Krishnamurti Advances to Round 3 of CTSI's Pitt Innovation...
www.gim-crhc.pitt.edu
We could not be more excited that Dr. Tamar Krishnamurti, PhD, and her 42 Days project are advancing to round three of the CTSI-sponsored Pitt Innovation Challenge (PInCh). As Dr. Krishnamurti and her team prepare for the next round of competition, we’re featuring our conversation in which she explains the basis of her team’s project and why she hopes to be one of the PInCh’s
Drunken Ultimatums ---CheckTagFinder--- The so-called ...www.nytimes.com › ideas › html_data › d-ideas-1
www.nytimes.com
The researchers Carey Morewedge and Tamar Krishnamurti, of Carnegie Mellon University, and Dan Ariely, of Duke, recently tested the competing explanations ...
sorted by relevance / date